GlaxoSmithKline: Tony Wood, chief scientific officer
Pharma firm GlaxoSmithKline (GSK) has designated Tony Wood to take on the role as chief scientific officer. He will assume full accountability in the position on August 1, taking over from current CSO Hal Barron.
Wood said, “I am honored to have been asked to lead GSK’s R&D; in the past few years, under Hal’s leadership, we have made enormous progress to strengthen the pipeline and put in place an R&D approach that can improve the efficiency and success of medicine and vaccine development. With the progress already made, and together with the many talented people we have working in our R&D organization, I am confident that we will deliver highly successful and much needed scientific innovation for patients in the years ahead.”
